Last updated on September 2014

This is a Gout study


Brief description of study

This is a Gout study

Detailed Study Description

This phase 2 study is a multicenter, exploratory study designed to evaluate the efficiency and safety of Febuxostat 40 mg in subjects with Gout and moderate renal impairment.

Clinical Study Identifier: TX139196

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.